Subhasis Roy

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.

Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008.

Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Cat Trail Capital LLC (Cat Trail Capital) is a private equity firm, a subsidiary of DEKKER FAMILY founded in 2004 by David Dekker. The fim is headquartered in Stamford, Connecticut.

Arcus Ventures is a venture capital firm founded in 2007 by James B. Dougherty and Steven L. Soignet. The firm is headquartered in New York.

Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland.

Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA.

Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA.

PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland.

Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.

Clarena AG provides business management consultancy services. The private company is based in Basel, Switzerland. The Swiss company was founded by Roger Meier.

Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang.

Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland.

Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland.

Vault Security Systems Corp. offers security solutions. The company is headquartered in Sunny Isles Beach, FL.

Part of Die Schweizerische Post AG, terreActive AG is a company that specializes in soar, security orchestration automation and response, ki, ai. The company is based in Aarau, Switzerland. terreActive was acquired by Die Schweizerische Post AG on July 04, 2023. The Swiss company's Security Operations Center is responsible for protecting the IT security infrastructure and preventing cyber attacks. The company was founded in 1996 by Marc-Yves Bächli, Roger Meier. Urs Rufer has been the CEO of the company since 1999.

SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer.

Nemis Technologies AG provides food safety solutions through their n-light environmental monitoring series. The company is based in Dübendorf, Switzerland and was founded in 2018 by Roger Meier, Arnaud Muller, Mario Hupfeld, and Urs Breitenstein. The Swiss company's E.coli rapid test is a part of this series and enables pathogen detection in food processing. Arnaud Muller has been the CEO since 2018.

Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier.